{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:54:47Z","timestamp":1794048887183,"version":"4.8.0"},"reference-count":70,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9,1]]},"abstract":"<jats:p>Lymphangioleiomyomatosis (LAM) is a rare disease characterized by proliferation of abnormal smooth-muscle cells in the lungs, leading to functional loss and sometimes lung transplantation. Although the origin of LAM cells is unknown, several features of LAM provide clues. First, LAM cells contain inactivating mutations in genes encoding Tsc1 or Tsc2, proteins that limit mTORC1 activity. Second, LAM tumors recur after lung transplantation, suggesting a metastatic pathogenesis. Third, LAM is found almost exclusively in women. Finally, LAM shares features with uterine leiomyomas, benign tumors of myometrial cells. From these observations, we proposed that LAM cells might originate from uterine leiomyomas containing Tsc mutations. To test our hypothesis, and to develop mouse models for leiomyoma and LAM, we targeted Tsc2 deletion primarily in uterine cells. In fact, nearly 100% of uteri from uterine-specific Tsc2 knockout mice developed myometrial proliferation and uterine leiomyomas by 12 and 24 weeks, respectively. Myometrial proliferation and mTORC1\/S6 activity were abrogated by the mTORC1 inhibitor rapamycin or by elimination of sex steroid production through ovariectomy or aromatase inhibition. In ovariectomized Tsc2 null mice, mTORC1\/S6 activity and myometrial growth were restored by estrogen but not progesterone. Thus, even without Tsc2, estrogen appears to be required for myometrial mTORC1\/S6 signaling and proliferation. Finally, we found Tsc2 null myometrial tumors in lungs of older Tsc2 uterine-specific knockout females, suggesting that lung LAM-like myometrial lesions may indeed originate from the uterus. This mouse model may improve our understanding of LAM and leiomyomas and might lead to novel therapeutic strategies for both diseases.<\/jats:p>","DOI":"10.1210\/me.2013-1059","type":"journal-article","created":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T04:42:35Z","timestamp":1372826555000},"page":"1403-1414","source":"Crossref","is-referenced-by-count":60,"title":["Uterine-Specific Loss of Tsc2 Leads to Myometrial Tumors in Both the Uterus and Lungs"],"prefix":"10.1210","volume":"27","author":[{"given":"Hen","family":"Prizant","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism (H.P., A.S., A.L., S.R.H.), Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritro","family":"Sen","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism (H.P., A.S., A.L., S.R.H.), Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Light","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism (H.P., A.S., A.L., S.R.H.), Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Nam","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology (S.-N.C., F.J.D.M., J.P.L.), Baylor College of Medicine, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco J.","family":"DeMayo","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology (S.-N.C., F.J.D.M., J.P.L.), Baylor College of Medicine, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Lydon","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Biology (S.-N.C., F.J.D.M., J.P.L.), Baylor College of Medicine, Houston, Texas 77030"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Hammes","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism (H.P., A.S., A.L., S.R.H.), Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"issue":"12","key":"2020071613275016100_B1","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1369\/jhc.4A6438.2004","article-title":"Combined smooth muscle and melanocytic differentiation in lymphangioleiomyomatosis","volume":"52","author":"Zhe","year":"2004","journal-title":"J Histochem Cytochem"},{"issue":"5","key":"2020071613275016100_B2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1272\/jnms.67.311","article-title":"Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features","volume":"67","author":"Ferrans","year":"2000","journal-title":"J Nihon Med Sch"},{"issue":"1","key":"2020071613275016100_B3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/lrb.2009.0024","article-title":"The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis","volume":"8","author":"Taveira-DaSilva","year":"2010","journal-title":"Lymphat Res Biol"},{"issue":"11","key":"2020071613275016100_B4","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1172\/JCI58709","article-title":"Lymphangioleiomyomatosis\u2014a wolf in sheep's clothing","volume":"122","author":"Henske","year":"2012","journal-title":"J Clin Invest"},{"issue":"6","key":"2020071613275016100_B5","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2353\/ajpath.2009.090525","article-title":"Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells","volume":"175","author":"Klarquist","year":"2009","journal-title":"Am J Pathol"},{"issue":"4","key":"2020071613275016100_B6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","article-title":"TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1","volume":"47","author":"Dibble","year":"2012","journal-title":"Mol Cell"},{"key":"2020071613275016100_B7","doi-asserted-by":"crossref","first-page":"61S","DOI":"10.1016\/S0012-3692(15)35466-0","article-title":"Pulmonary cysts consistent with lymphangioleiomyomatosis are common in women with tuberous sclerosis: genetic and radiographic analysis","volume":"121","author":"McCormack","year":"2002","journal-title":"Chest"},{"issue":"1","key":"2020071613275016100_B8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/lrb.2009.0020","article-title":"mTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the \u201cperfect storm\u201d of pro-metastatic factors in LAM pathogenesis","volume":"8","author":"Yu","year":"2010","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"2020071613275016100_B9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/lrb.2009.0018","article-title":"Lymphangioleiomyomatosis: a disease involving the lymphatic system","volume":"8","author":"Seyama","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"2020071613275016100_B10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1196\/annals.1413.018","article-title":"Lymphatic involvement in lymphangioleiomyomatosis","volume":"1131","author":"Glasgow","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2020071613275016100_B11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/jmg.37.1.55","article-title":"Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis","volume":"37","author":"Astrinidis","year":"2000","journal-title":"J Med Genet"},{"issue":"7","key":"2020071613275016100_B12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/rccm.200208-969OC","article-title":"Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism","volume":"167","author":"Karbowniczek","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2020071613275016100_B13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1086\/301804","article-title":"Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis","volume":"62","author":"Smolarek","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"11","key":"2020071613275016100_B14","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2020071613275016100_B15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10038-002-8651-8","article-title":"Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis","volume":"47","author":"Sato","year":"2002","journal-title":"J Hum Genet"},{"issue":"7","key":"2020071613275016100_B16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/thx.54.7.618","article-title":"Pulmonary lymphangioleiomyomatosis in Korea","volume":"54","author":"Oh","year":"1999","journal-title":"Thorax"},{"issue":"12","key":"2020071613275016100_B17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/thorax.55.12.1052","article-title":"Clinical experience of lymphangioleiomyomatosis in the UK","volume":"55","author":"Johnson","year":"2000","journal-title":"Thorax"},{"issue":"2, Pt 1","key":"2020071613275016100_B18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/ajrccm.151.2.7842216","article-title":"Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors","volume":"151","author":"Kitaichi","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2020071613275016100_B19","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1073\/pnas.0810790106","article-title":"Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells","volume":"106","author":"Yu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2020071613275016100_B20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1210\/jc.2007-1283","article-title":"Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase-induced cell invasiveness","volume":"93","author":"Glassberg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071613275016100_B21","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1378\/chest.126.6.1867","article-title":"Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone","volume":"126","author":"Taveira-DaSilva","year":"2004","journal-title":"Chest"},{"issue":"2","key":"2020071613275016100_B22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1164\/ajrccm.160.2.9901027","article-title":"Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment","volume":"160","author":"Johnson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2020071613275016100_B23","first-page":"916","article-title":"Successful treatment of pulmonary lymphangiomyomatosis with oophorectomy and progesterone","volume":"132","author":"Adamson","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"2020071613275016100_B24","first-page":"139","article-title":"Pulmonary lymphangioleiomyomatosis in a postmenopausal woman: case report with review of literature","volume":"58","author":"Khalife","year":"2005","journal-title":"S D J Med"},{"issue":"12","key":"2020071613275016100_B25","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1097\/PAS.0b013e318235edbd","article-title":"Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients","volume":"35","author":"Hayashi","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2020071613275016100_B26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0046-8177(00)80210-5","article-title":"Benign metastasizing leiomyoma: a cytogenetically balanced but clonal disease","volume":"31","author":"Tietze","year":"2000","journal-title":"Hum Pathol"},{"issue":"5","key":"2020071613275016100_B27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cancergen.2012.04.005","article-title":"Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis","volume":"205","author":"Bowen","year":"2012","journal-title":"Cancer Genet"},{"issue":"5","key":"2020071613275016100_B28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.coc.0000037737.78080.E3","article-title":"Benign metastasizing leiomyomatosis: case report and review","volume":"26","author":"Goyle","year":"2003","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"2020071613275016100_B29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/OGX.0b013e3181d60f93","article-title":"Pathogenesis of benign metastasizing leiomyoma: a review","volume":"65","author":"Awonuga","year":"2010","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"2020071613275016100_B30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/dvg.20271","article-title":"Generation of a conditional disruption of the Tsc2 gene","volume":"45","author":"Hernandez","year":"2007","journal-title":"Genesis"},{"issue":"2","key":"2020071613275016100_B31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/gene.20098","article-title":"Cre-mediated recombination in cell lineages that express the progesterone receptor","volume":"41","author":"Soyal","year":"2005","journal-title":"Genesis"},{"issue":"14","key":"2020071613275016100_B32","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1158\/0008-5472.CAN-08-1274","article-title":"Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice","volume":"68","author":"Daikoku","year":"2008","journal-title":"Cancer Res"},{"issue":"26","key":"2020071613275016100_B33","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1038\/onc.2010.126","article-title":"The synergistic effect of Mig-6 and Pten ablation on endometrial cancer development and progression","volume":"29","author":"Kim","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"2020071613275016100_B34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/gcc.20118","article-title":"Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models","volume":"42","author":"Lee","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2020071613275016100_B35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","article-title":"Effects of rapamycin in the Eker rat model of tuberous sclerosis complex","volume":"57","author":"Kenerson","year":"2005","journal-title":"Pediatr Res"},{"issue":"3","key":"2020071613275016100_B36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"issue":"6, Pt 1","key":"2020071613275016100_B37","first-page":"E1112","article-title":"Estrogen receptors (ER\u03b1\/ER\u03b2) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma","volume":"276","author":"Benassayag","year":"1999","journal-title":"Am J Physiol"},{"issue":"3","key":"2020071613275016100_B38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1098-2744(199611)17:3<151::AID-MC7>3.0.CO;2-I","article-title":"Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators","volume":"17","author":"Fuchs-Young","year":"1996","journal-title":"Mol Carcinog"},{"issue":"3","key":"2020071613275016100_B39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1354\/vp.08-VP-0180-N-BC","article-title":"Hydronephrosis and urine retention in estrogen-implanted athymic nude mice","volume":"46","author":"Gakhar","year":"2009","journal-title":"Vet Pathol"},{"issue":"2","key":"2020071613275016100_B40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1095\/biolreprod35.2.475","article-title":"Hormonal regulation of estrogen and progestin receptors in decidual cells","volume":"35","author":"Leavitt","year":"1986","journal-title":"Biol Reprod"},{"issue":"12","key":"2020071613275016100_B41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-154-12-201106210-00007","article-title":"Changes in lung function and chylous effusions in patients with lymphangioleiomyomatosis treated with sirolimus","volume":"154","author":"Taveira-DaSilva","year":"2011","journal-title":"Ann Intern Med"},{"issue":"7","key":"2020071613275016100_B42","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/hmg\/ddq570","article-title":"Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin","volume":"20","author":"Malhowski","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"17","key":"2020071613275016100_B43","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"2020071613275016100_B44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"New Engl J Med"},{"issue":"5","key":"2020071613275016100_B45","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MCP.0b013e328349ac8c","article-title":"Current management of lymphangioleiomyomatosis","volume":"17","author":"Taill\u00e9","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"2020071613275016100_B46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1513\/pats.200909-104JS","article-title":"Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy","volume":"7","author":"Yu","year":"2010","journal-title":"Proc Am Thorac Soc"},{"issue":"1","key":"2020071613275016100_B47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/lrb.2009.0027","article-title":"Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis","volume":"8","author":"Kinder","year":"2010","journal-title":"Lymphat Res Biol"},{"key":"2020071613275016100_B48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/rp.57.1.277","article-title":"Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma","volume":"57","author":"Walker","year":"2002","journal-title":"Recent Prog Horm Res"},{"issue":"10","key":"2020071613275016100_B49","first-page":"1503","article-title":"Uterine fibroid tumors: diagnosis and treatment","volume":"75","author":"Evans","year":"2007","journal-title":"Am Fam Physician"},{"key":"2020071613275016100_B50","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.rmed.2010.03.017","article-title":"Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies","volume":"104","author":"Glasgow","year":"2010","journal-title":"Respir Med"},{"issue":"3, Pt 1","key":"2020071613275016100_B51","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm.161.3.9904009","article-title":"Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study","volume":"161","author":"Matsui","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"2020071613275016100_B52","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/thx.49.9.910","article-title":"Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study","volume":"49","author":"Wahedna","year":"1994","journal-title":"Thorax"},{"issue":"3","key":"2020071613275016100_B53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0020-7292(95)02619-3","article-title":"Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax","volume":"52","author":"Brunelli","year":"1996","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"2020071613275016100_B54","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.rmed.2008.11.007","article-title":"Pregnancy experiences among women with lymphangioleiomyomatosis","volume":"103","author":"Cohen","year":"2009","journal-title":"Respir Med"},{"issue":"4","key":"2020071613275016100_B55","doi-asserted-by":"crossref","first-page":"L694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways","volume":"286","author":"Yu","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"8","key":"2020071613275016100_B56","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2174\/138920206779315737","article-title":"Estrogen signaling multiple pathways to impact gene transcription","volume":"7","author":"Marino","year":"2006","journal-title":"Curr Genomics"},{"issue":"5","key":"2020071613275016100_B57","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/jc.2008-2093","article-title":"Progestins activate the AKT pathway in leiomyoma cells and promote survival","volume":"94","author":"Hoekstra","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2020071613275016100_B58","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"issue":"4","key":"2020071613275016100_B59","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0007-0971(85)90077-4","article-title":"A report of two long-surviving cases of pulmonary lymphangioleiomyomatosis and the response to progesterone therapy","volume":"79","author":"Sawicka","year":"1985","journal-title":"Br J Dis Chest"},{"issue":"4","key":"2020071613275016100_B60","first-page":"258","article-title":"Lymphangioleiomyomatosis\u2014treatment with progesterone","volume":"32","author":"Poh","year":"1991","journal-title":"Singapore Med J"},{"issue":"1","key":"2020071613275016100_B61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/hupa.2003.50","article-title":"Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis","volume":"34","author":"Bittmann","year":"2003","journal-title":"Hum Pathol"},{"issue":"6","key":"2020071613275016100_B62","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/j.athoracsur.2011.12.047","article-title":"Benign metastasizing leiomyoma: a rare cause of multiple pulmonary nodules","volume":"93","author":"Rege","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"2020071613275016100_B63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5761\/atcs.cr.11.01688","article-title":"Benign metastasizing leiomyoma of the lung","volume":"18","author":"Goto","year":"2012","journal-title":"Ann Thorac Cardiovasc Surg"},{"issue":"4","key":"2020071613275016100_B64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/gcc.10281","article-title":"Uterine leiomyoma in the Eker rat: a unique model for important diseases of women","volume":"38","author":"Walker","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2020071613275016100_B65","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/lrb.2009.0013","article-title":"Animal models of lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC)","volume":"8","author":"Kwiatkowski","year":"2010","journal-title":"Lymphat Res Biol"},{"issue":"5","key":"2020071613275016100_B66","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","article-title":"A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells","volume":"11","author":"Kwiatkowski","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"15","key":"2020071613275016100_B67","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1073\/pnas.151033798","article-title":"A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice","volume":"98","author":"Kobayashi","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2020071613275016100_B68","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J Clin Invest"},{"issue":"6","key":"2020071613275016100_B69","doi-asserted-by":"crossref","first-page":"e38589","DOI":"10.1371\/journal.pone.0038589","article-title":"Real-time monitoring of tumorigenesis, dissemination, drug response in a preclinical model of lymphangioleiomyomatosis\/tuberous sclerosis complex","volume":"7","author":"Liu","year":"2012","journal-title":"PloS one"},{"issue":"154","key":"2020071613275016100_B70","doi-asserted-by":"crossref","first-page":"154ra134","DOI":"10.1126\/scitranslmed.3003840","article-title":"Prevention of alveolar destruction and airspace enlargement in a mouse model of pulmonary lymphangioleiomyomatosis (LAM)","volume":"4","author":"Goncharova","year":"2012","journal-title":"Sci Transl Med"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/27\/9\/1403\/8939391\/mend1403.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/27\/9\/1403\/8939391\/mend1403.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T23:52:55Z","timestamp":1594943575000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/27\/9\/1403\/2615090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,1]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2013-1059","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,1]]}}}